Literature DB >> 6112074

Adaptation to prolonged beta-blockade of rabbit atrial, purkinje, and ventricular potentials, and of papillary muscle contraction. Time-course of development of and recovery from adaptation.

A E Raine, E M Vaughan Williams.   

Abstract

Groups of littermate rabbits were treated for various periods up to 6 weeks with twice daily subcutaneous injections of saline, D-propranolol, DL-propranolol, or metoprolol, the latter two at doses equivalent to those used in clinical therapy. Investigations were made at a sufficient time (20-24 hours after the most recent dose) to ensure that the drugs would have been eliminated from the body, so that any observed changes would represent an adaptation to treatment, not effects due to the presence of the drugs. The ECG was recorded in vivo at regular intervals during treatment. After several days, Q-Tc was prolonged by the beta-blockers, reaching a peak effect at about 3 weeks from the start of treatment, and returned to control values at 3 weeks after cessation of treatment. Action potential duration, measured in vitro by intracellular recording, was also prolonged uniformly in atria and ventricles over a similar time-course, unrelated to cardiac frequency, but shortened in distal Purkinje cells. Peak tension was not altered in propranolol-adapted papillary muscles, but the relationship of rate of rise of tension was steeper. It is concluded that these effects represent a myocardial adaptation to prolonged beta-blockade.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6112074     DOI: 10.1161/01.res.48.6.804

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  18 in total

1.  Remodelling of human atrial K+ currents but not ion channel expression by chronic β-blockade.

Authors:  Gillian E Marshall; Julie A Russell; James O Tellez; Pardeep S Jhund; Susan Currie; John Dempster; Mark R Boyett; Kathleen A Kane; Andrew C Rankin; Antony J Workman
Journal:  Pflugers Arch       Date:  2011-12-08       Impact factor: 3.657

Review 2.  Modulation of the QT interval duration in hypertension with antihypertensive treatment.

Authors:  Jan Klimas; Peter Kruzliak; Simon W Rabkin
Journal:  Hypertens Res       Date:  2015-03-19       Impact factor: 3.872

3.  Effect of long term treatment with metoprolol and sotalol on ventricular repolarisation measured by use of transoesophageal atrial pacing.

Authors:  C Blomström-Lundqvist; M Dohnal; I Hirsch; A Lindblad; A Hjalmarson; S B Olsson; N Edvardsson
Journal:  Br Heart J       Date:  1986-02

4.  Effects of selective alpha 1-, alpha 2-, beta 1-and beta 2-adrenoceptor stimulation on potentials and contractions in the rabbit heart.

Authors:  I D Dukes; E M Vaughan Williams
Journal:  J Physiol       Date:  1984-10       Impact factor: 5.182

5.  Comparison of the effects of acute and chronic beta-blockade on infarct size in the dog after circumflex occlusion.

Authors:  D E Euler; P J Hughes; P J Scanlon
Journal:  Cardiovasc Drugs Ther       Date:  1988-07       Impact factor: 3.727

6.  Beta adrenergic receptor blockade of feline myocardium. Cardiac mechanics, energetics, and beta adrenoceptor regulation.

Authors:  G Cooper; R L Kent; P McGonigle; A M Watanabe
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

Review 7.  Cardiac adrenergic control and atrial fibrillation.

Authors:  Antony J Workman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-12-04       Impact factor: 3.000

Review 8.  Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.

Authors:  A Fitton; E M Sorkin
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

9.  Effects of metoprolol on action potential and membrane currents in guinea-pig ventricular myocytes.

Authors:  J Sánchez-Chapula
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-03       Impact factor: 3.000

10.  Cellular bases for human atrial fibrillation.

Authors:  Antony J Workman; Kathleen A Kane; Andrew C Rankin
Journal:  Heart Rhythm       Date:  2008-01-17       Impact factor: 6.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.